blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3690044

EP3690044 - CRISPR ENABLED MULTIPLEXED GENOME ENGINEERING [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  08.12.2023
Database last updated on 15.06.2024
FormerGrant of patent is intended
Status updated on  07.08.2023
FormerExamination is in progress
Status updated on  03.06.2022
FormerRequest for examination was made
Status updated on  25.12.2020
FormerThe application has been published
Status updated on  03.07.2020
Most recent event   Tooltip08.12.2023(Expected) grantpublished on 10.01.2024  [2024/02]
Applicant(s)For all designated states
The Regents of the University of Colorado, a body corporate
1800 Grant Street, 8th Floor
Denver, CO 80203 / US
[2020/32]
Inventor(s)01 / GILL, Ryan, T.
2025 Ash Street
Denver, CO 80227 / US
02 / GARST, Andrew
5505 Valmont Road 1
Boulder, CO 80301 / US
 [2020/32]
Representative(s)Boult Wade Tennant LLP
Salisbury Square House
8 Salisbury Square
London EC4Y 8AP / GB
[2020/32]
Application number, filing date20161652.111.02.2015
[2020/32]
Priority number, dateUS201461938608P11.02.2014         Original published format: US 201461938608 P
[2020/32]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3690044
Date:05.08.2020
Language:EN
[2020/32]
Type: B1 Patent specification 
No.:EP3690044
Date:10.01.2024
Language:EN
[2024/02]
Search report(s)(Supplementary) European search report - dispatched on:EP25.05.2020
ClassificationIPC:C12N15/10, C12N15/11, C12N15/90, C40B40/08, C40B50/06, C12N9/22
[2023/35]
CPC:
C12N15/902 (EP,GB,IL,US); C12N15/102 (EP,GB,IL,KR,US); C12N15/1024 (IL,US);
C12N15/1082 (IL,US); C12N15/1093 (IL,US); C12N15/11 (IL,US);
C12N15/111 (EP,GB,IL,KR,US); C12N15/113 (KR); C12N15/63 (KR);
C12N9/22 (EP,IL,KR,US); C40B40/08 (EP,GB,IL,US); C40B50/06 (EP,GB);
C12N2310/10 (EP,IL,US); C12N2310/20 (EP,IL,KR,US); C12N2310/531 (KR);
C12N2320/11 (EP,IL,US); C12N2320/12 (EP,GB,IL,US); C12N2330/31 (EP,GB,IL,KR,US) (-)
Former IPC [2020/32]C12N15/11, C12N15/00, C12N15/86, A01N63/00, C40B20/04, C40B30/04, C40B40/08
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/04]  
Former [2020/32]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:CRISPR-AKTIVIERTES MULTIPLEXED-GENOM-ENGINEERING[2020/32]
English:CRISPR ENABLED MULTIPLEXED GENOME ENGINEERING[2020/32]
French:INGÉNIERIE GÉNOMIQUE MULTIPLEXE VALIDÉE AYANT RECOURS AU SYSTÈME CRISPR[2020/32]
Examination procedure17.12.2020Amendment by applicant (claims and/or description)
17.12.2020Examination requested  [2021/04]
17.12.2020Date on which the examining division has become responsible
02.06.2022Despatch of a communication from the examining division (Time limit: M04)
11.10.2022Reply to a communication from the examining division
08.08.2023Communication of intention to grant the patent
05.12.2023Fee for grant paid
05.12.2023Fee for publishing/printing paid
05.12.2023Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP15749644.9  / EP3105328
Divisional application(s)EP21200160.6  / EP3985114
EP22164530.2  / EP4063503
Fees paidRenewal fee
18.03.2020Renewal fee patent year 03
18.03.2020Renewal fee patent year 04
18.03.2020Renewal fee patent year 05
18.03.2020Renewal fee patent year 06
12.02.2021Renewal fee patent year 07
14.02.2022Renewal fee patent year 08
23.02.2023Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO2013176772  (UNIV CALIFORNIA [US], et al) [A] 1-13 * paragraphs [0010] , [0 11] , [0 26] *;
 [XPI]  - PINES GUR ET AL, Codon Compression Algorithms for Saturation Mutagenesis, ACS SYNTHETIC BIOLOGY, VOL. 4, NR. 5, PAGE(S) 604-614, (20141010), ISSN 2161-5063(print), XP002771109 [XP] 1,10,12,13 * page 608, column 2, paragraph 3 - page 609, column 1, paragraph 1; figure 5 * * page 613, column 1, line 3 - page 613, column 2, line 2 * [I] 2-9,11
 [A]  - M. JINEK ET AL, "A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity", SCIENCE, (20120817), vol. 337, no. 6096, doi:10.1126/science.1225829, ISSN 0036-8075, pages 816 - 821, XP055299674 [A] 1-13 * the whole document *

DOI:   http://dx.doi.org/10.1126/science.1225829
 [A]  - WENYAN JIANG ET AL, "RNA-guided editing of bacterial genomes using CRISPR-Cas systems", NATURE BIOTECHNOLOGY, us, (20130301), vol. 31, no. 3, doi:10.1038/nbt.2508, ISSN 1087-0156, pages 233 - 239, XP055545605 [A] 1-13 * page 233, column 2, paragraph 2 * * Online suppl. Figure 2; page 234, column 1, paragraphs 1-3; figures 1A,B *

DOI:   http://dx.doi.org/10.1038/nbt.2508
 [A]  - BIKARD DAVID ET AL, "CRISPR Interference Can Prevent Natural Transformation and Virulence Acquisition during In Vivo Bacterial Infection", vol. 12, no. 2, doi:10.1016/J.CHOM.2012.06.003, ISSN 1931-3128, (20120816), pages 177 - 186, CELL HOST & MICROBE, ELSEVIER, NL, URL: https://www.sciencedirect.com/science/article/pii/S1931312812002296?via%3Dihub, (20120815), XP028934538 [A] 1-13 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.chom.2012.06.003
by applicant   - JINEK et al., Science, (20120000), vol. 337, no. 6096, pages 816 - 821
    - CONG et al., Science, (20130000), vol. 339, no. 6121, pages 819 - 823
    - DICARLO et al., Nucleic Acids Res., (20130000), vol. 41, pages 4336 - 4343
    - WAAIJERS et al., Genetics, (20130000), vol. 195, pages 1187 - 1191
    - WANG et al., Cell, (20130000), vol. 153, pages 273 - 297
    - BROUNS et al., Science, (20080000), vol. 321, pages 960 - 964
    - SEMENOVA et al., PNAS, (20110000), vol. 108, pages 10098 - 10103
    - DATTA et al., Gene, (20080000), vol. 379, pages 109 - 115
    - CONSTANTINO et al., PNAS, (20030000), vol. 100, pages 15748 - 15753
    - WANG et al., Nature, (20090000), vol. 460, pages 894 - 898
    - WANG et al., Nat. Methods, (20120000), vol. 9, pages 591 - 593
    - WARNER et al., Nat. Biotechnol, (20100000), vol. 28, pages 856 - 862
    - WANG et al., Nature, (20080000), vol. 460, pages 894 - 898
    - BHAYA et al., Ann. Rev. of Genetics, (20110000), vol. 45, pages 273 - 297
    - WITHERS et al., App. Environ. Microbiol, (20070000), vol. 73, pages 6277 - 6283
    - ZHENG et al., Biotechnol. for biofuels, (20130000), vol. 6, page 57
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.